英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

reposeful    
a. 平稳的,沉着的

平稳的,沈着的

reposeful
adj 1: affording physical or mental rest; "she spent a restful
night at home" [synonym: {restful}, {reposeful}, {relaxing}]
[ant: {restless}, {uneasy}]

Reposeful \Re*pose"ful\ (r[-e]*p[=o]z"f[.u]l), a.
Full of repose; quiet.
[1913 Webster]


请选择你想看的字典辞典：
单词字典翻译
reposeful查看　reposeful　在百度字典中的解释百度英翻中〔查看〕
reposeful查看　reposeful　在Google字典中的解释Google英翻中〔查看〕
reposeful查看　reposeful　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Libtayo: Uses, Side Effects, Warnings - Drugs. com
    Libtayo (cemiplimab-rwlc) is used to treat metastatic cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer Includes Libtayo side effects, interactions and indications
  • LIBTAYO® (cemiplimab-rwlc) in Advanced NSCLC, BCC, CSCC High-Risk CSCC
    LIBTAYO is a prescription medicine used to treat adults with a type of skin cancer called basal cell carcinoma (BCC) when your BCC cannot be removed by surgery (locally advanced BCC) or when it has spread (metastatic BCC) and have previously received treatment with a hedgehog pathway inhibitor (HHI), or cannot receive treatment with a HHI
  • Libtayo (cemiplimab-rwlc) FDA Approval History - Drugs. com
    Libtayo (cemiplimab-rwlc) is a programmed death receptor-1 (PD-1) blocking antibody for the treatment of cutaneous squamous cell carcinoma (CSCC), basal cell carcinoma (BCC), and non-small cell lung cancer (NSCLC) Cutaneous Squamous Cell Carcinoma (CSCC) Libtayo is indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC
  • Libtayo (cemiplimab) dosing, indications, interactions, adverse effects . . .
    Medscape - Cutaneous squamous cell carcinoma and basal cell carcinoma dosing for Libtayo (cemiplimab), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy lactation schedules, and cost information
  • Cemiplimab-rwlc - NCI - National Cancer Institute
    Cemiplimab-rwlc is a type of drug called an immune checkpoint inhibitor (a type of immunotherapy) It is a monoclonal antibody that binds to the protein PD-1 on the surface of immune cells called T cells It works by keeping cancer cells from suppressing the immune system This allows the immune system to attack and kill the cancer cells
  • Cemiplimab-rwlc (intravenous route) - Side effects uses
    Cemiplimab-rwlc injection is also used to treat a type of skin cancer called basal cell carcinoma (BCC) that cannot be removed by surgery (locally advanced) or that has spread (metastatic) in patients who have received previous treatment with a hedgehog pathway inhibitor (HHI) or who cannot receive treatment with a HHI
  • Cemiplimab-rwlc (Libtayo) Updates 2025: Uses in cancer, Side effects . . .
    This article is about Cemiplimab-rwlc (Libtayo), its uses, side effects, dosage, and what to expect during treatment
  • Libtayo more favorable than Keytruda for first-line treatment of . . .
    Libtayo's lower cost and superior safety profile compared to Keytruda drive its cost-effectiveness, making it a favorable first-line treatment option The findings provide critical insights for optimizing treatment strategies for advanced NSCLC, aiding clinicians and policymakers in decision-making
  • Libtayo (Cemiplimab-rwlc Injection): Side Effects, Uses . . . - RxList
    Libtayo (Cemiplimab-rwlc Injection) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources





中文字典-英文字典  2005-2009